CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 64 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-16 | Silva Francisco VP of Research and Development | Purchase | +4,000 | $6.63 | $27K | 7,829 |
| 2021-11-04 | Kristal Robert Eugene Chief Financial Officer | Grant or award · Stock Option | +10,490 | 10,490 | ||
| 2021-11-04 | Rosa David A Director | Grant or award · Stock Option | +10,490 | 10,490 | ||
| 2021-11-04 | Williams Patrick F. Director | Grant or award · Stock Option | +10,490 | 10,490 | ||
| 2021-11-04 | Silva Francisco VP of Research and Development | Returned to the company · Stock Option | −293,479 | 0 | ||
| 2021-11-04 | Silva Francisco VP of Research and Development | Grant or award · Stock Option | +293,479 | 293,479 | ||
| 2021-11-04 | Silva Francisco VP of Research and Development | Grant or award · Stock Option | +42,059 | 42,059 | ||
| 2021-11-04 | Kukekov Nickolay V. Director | Grant or award · Stock Option | +25,236 | 25,236 | ||
| 2021-11-04 | ALSTODT LANCE President, CEO, COB | Returned to the company · Stock Option | −293,479 | 0 | ||
| 2021-11-04 | ALSTODT LANCE President, CEO, COB | Grant or award · Stock Option | +293,479 | 293,479 | ||
| 2021-11-04 | ALSTODT LANCE President, CEO, COB | Grant or award · Stock Option | +42,059 | 42,059 | ||
| 2021-03-18 | Silva Francisco VP of Research and Development | Grant or award | +586,958,987 | 595,390,616 | ||
| 2021-03-18 | Silva Francisco VP of Research and Development | Grant or award · Stock Option | +1,173,917,974 | 1,173,917,974 | ||
| 2021-03-18 | ALSTODT LANCE President, CEO, COB | Grant or award | +586,958,987 | 605,670,653 | ||
| 2021-03-18 | ALSTODT LANCE President, CEO, COB | Grant or award · Stock Option | +1,173,917,974 | 1,173,917,974 | ||
| 2020-11-23 | ALSTODT LANCE President, CEO, COB | Other acquisition | +18,661,666 | 18,711,666 | ||
| 2020-11-23 | Silva Francisco VP of Research and Development | Other acquisition | +8,375,671 | 8,431,629 | ||
| 2020-01-06 | Broadrick Dale 10% owner | Purchase | +3,750,000 | $0.01 | $51K | 12,549,712 |
| 2020-01-06 | Broadrick Dale 10% owner | Purchase | +4,710,210 | $0.01 | $52K | 5,823,795 |
| 2019-12-09 | Broadrick Dale 10% owner | Purchase | +81,000 | $0.04 | $3K | 1,113,585 |
Page 9 of 30 · 598 trades